Osivax publishes phase 2a results of OVX836-004 st...
Category : Clinical Trial Update 14 July 2025Overview Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protec...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Overview Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protec...
Overview Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced new data from its clinica...
Overview Ultragenyx Pharmaceutical Inc, a biopharma company committed to bringing novel therapies...
Overview Quest Diagnostics, a leader in diagnostic information services, including advanced diagn...
Overview Merck, known as MSD outside of the United States and Canada, announced that the US Food...